Dr. Robert Lowsky, MD

Dr. Lowsky practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Lowsky's NPI, 1083756308, was assigned on February 13, 2007. Dr. Lowsky graduated from McGill University Faculty of Medicine in 1988. Dr. Lowsky holds California license C50659.

Dr. Lowsky's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Lowsky's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Lowsky to 1 more hospital, named with a free account. Dr. Lowsky's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lowsky practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Lowsky's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Lowsky is licensed in California.

Dmand AI lists lymphoma and multiple myeloma among the conditions Dr. Lowsky treats.

CMS data shows 254 Medicare services from Dr. Lowsky across 2 procedure codes in 2024, for 82 Medicare patients. Medicare paid $30,497 for them.

CMS counts 82 Medicare patients who saw Dr. Lowsky in 2024. The largest group is 65 to 74, with 55 patients. 59% of them have high cholesterol, and 55% have high blood pressure. 23% are also on Medicaid. Their average risk score is 3.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lowsky's median patient age at 62, with 35% women.

In 2024, Dr. Lowsky wrote 477 Medicare Part D claims for 54 patients. 72% of them were for generic drugs. CMS names the drug for 338 of them, across 13 drugs with 11 or more claims each, at $1,703,213 in total drug cost. In 2023, CMS named 382 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Lowsky for performance year 2024, reported as part of a group. Dr. Lowsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lowsky as offering telehealth.

Dmand AI links 84 papers to Dr. Lowsky, published from 2004 to 2025. 2024 was the busiest year, with 8. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation Conditioning and Graft vs Host Disease. Dr. Lowsky has published most often in Bone Marrow Transplant. Dr. Lowsky's most frequent co-authors are Robert Stuart Negrin, MD, Sally Arai, MD and David Bernard Miklos, MD, PhD.

Dmand AI links Dr. Lowsky to 14 clinical trials, 7 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Hematologic Neoplasms, Myeloproliferative Disorders and Graft vs Host Disease. Stanford University sponsors the most, 9.

CMS Open Payments shows 3 general payments to Dr. Lowsky from 2 drug and device companies from 2016 to 2019. Consulting fees make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $10,625.

Dmand AI lists 1 award for Dr. Lowsky, most recently CMS Stage 1 EHR in 2012.

Dr. Lowsky graduated from McGill University Faculty of Medicine in 1988.

Dr. Lowsky is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.